Dual hereditary jaundice, a combination of Dubin-Johnson and Gilbert's syndromes, is a rare clinical entity resulting from the compound defects of bilirubin conjugation and transport. We aimed to study the hereditary jaundice in 56 members from seven seemingly unrelated Roma families, to find the causal genetic defect and to estimate its origin in Roma population. On the basis of biochemical results of total and conjugated serum bilirubin and clinical observations, ABCC2 gene, TATA box and phenobarbital enhancer (PBREM) of UGT1A1 gene were analyzed by sequencing, RFLP and fragment analysis. We found a novel variant c.1013_1014delTG in the eighth exon of ABCC2 gene in 17 individuals in homozygous state. Dual defect NG_011798.1:c.[1013_1014delTG]; NG_002601.2:g.[175492_175493insTA] in homozygous state was found in four subjects. Biochemical analyses of porphyrins and coproporphyrin isomers in urine performed by HPLC showed inverted ratio of excreted coproporphyrin, with the predominance of coproporphyrin I (up to 100%), typical for patients with Dubin-Johnson syndrome. Pursuant cultural and social specifics of the population led us to suspect a founder effect; therefore, we performed a haplotype study using genotyping data from Affymetrix Genome-Wide Human SNP Array 6.0. As a result, we detected a common 86 kbp haplotype encompassing promoter and part of the ABCC2 coding region among all families, and estimated the age of the ancestral variant to 178-185 years. In this study, we found a novel deletion in ABCC2 gene, described genetic and biochemical features of dual hereditary jaundice and confirmed the existence of founder effect and common haplotype among seven Roma families.

Department of Medical Genetics Alpha Medical Spisska Nova Ves Slovakia

Department of Pediatrics 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Czech Republic

Department of Pediatrics P J Safarik University Kosice Vienna Slovakia

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Czech Republic

Institute of Medical Genetics University of Vienna Vienna Austria

Eur J Hum Genet. 2016 Oct;24(10):1515. doi: 10.1038/ejhg.2016.51. PubMed

Zobrazit více v PubMed

Dubin I, Johnson FB: Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinicopathologic entity with report of 12 cases. Medicine 1954; 33: 155. PubMed

Kitamura T, Hardenbrook C, Kamimoto Y et al: Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR2) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci USA 1990; 87: 3557–3561. PubMed PMC

Mor-Cohen R, Zivelin A, Rosenberg N et al: Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 2001; 276: 36923–36930. PubMed

Keitel V, Nies AT, Brom M et al: A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003; 284: G165–G174. PubMed

Elferink O, Ottenhoff R, Liefting WG et al: ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. Am J Physiol 1990; 258: G669–G706. PubMed

Chen ZS, Kawabe T, Ono M et al: Effect of multidrug resistance-reversing agents on transorting activity of human canalicular resistance multispecific organic anion transporter. Mol Pharmacol 1999; 56: 1219–1228. PubMed

Evers R, de Haas M, Sparidans R et al: Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 2000; 83: 375–383. PubMed PMC

van Zanden JJ, de Mul A, Wortelboer HM et al: Reversal of PubMed

Wada M, Toh S, Taniguchi K et al: Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet 1998; 7: 203–207. PubMed

Mor-Cohen R, Zivelin A, Rosenberg N, Goldberg I, Seligsohn U: A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients. Hepatol Res 2005; 31: 104–111. PubMed

Bosma PJ, Chowdhury A, Bakker C et al: Genetic basis of reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333: 1171–1175. PubMed

Sugatani J, Yamakawa K, Yoshinari K et al: Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Com 2002; 292: 492–497. PubMed

Arias IM, London IM: Bilirubin glucuronide formation PubMed

Cebecauerova D, Jirasek T, Budisova L et al: Dual hereditary Jaundice: simultaneous occurence of mutations causing Gilbert's and Dubin-Johnson syndrome. Gastroenterology 2005; 129: 315–320. PubMed

Gresham D, Morar B, Underhill PA et al: Origins and divergene of Roma (gypsies). Am J Hum Genet 2001; 69: 1314–1331. PubMed PMC

Mendizabal I, Lao O, Marigorta UM et al: Reconstructing the population history of European Romani from genome-wide data. Curr Biol 2012; 22: 2342–2349. PubMed

Kalaydjieva L, Morar B, Chaix R, Tang H: A newly discovered founder population: the Roma/Gypsies. Bioessays 2005; 27: 1084–1094. PubMed

Purcell S, Neale B, Todd-Brown K et al: PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007; 81: 559–575. PubMed PMC

Kimmel G, Shamir R Maximum Likelihood Resolution of Multi-block Genotypes. Proceedings of the Eighth Annual International Conference on Research in Computational Molecular Biology (RECOMB); New York, NY, USA, 2004, pp 2–6.

Kimmel G, Shamir R: GERBIL: genotype resolution and block identification using likelihood. Proc Natl Acad Sci USA 2005; 102: 158–162. PubMed PMC

Austerlitz F, Kalaydjieva L, Heyer E: Detecting population growth, selection and inherited fertility from haplotypic data in humans. Genetics 2003; 165: 1579–1586. PubMed PMC

Sprocha B: Prognosis of Roma population in Slovakia to year 2013. Slovak Stat Demogr 2011; 21: 22–46.

Koskelo P, Toivonen I, Adlercreutz H: Urinary coproporphyrin isomer distribution in the Dubin-Johnson syndrome. Clin Chem 1967; 13: 1006–1009. PubMed

Kondo T, Kuchiba K, Shimizu Y: Coporporphyrin isomers in Dubin-Johnson syndrome. Gastroenterology 1976; 70: 1117–1120. PubMed

Owens D, Evans J: Population studies on Gilbert's syndrome. J Med Genet 1975; 12: 152–156. PubMed PMC

Cherrington NJ, Hartley DP, Li N et al: Organ distribution of multidrug resistence proteins 1, 2 and 3 (MRP1, 2 and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 2002; 300: 97–104. PubMed

van de Steeg E, Stranecky V, Hartmannova H et al: Complete OATP1B and OTP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest 2012; 122: 519–528. PubMed PMC

Lankish TO, Schultz C, Zwingers T et al: Gilbert's syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 695–701. PubMed

Koike K, Kawabe T, Tanaka T et al: Multispecific organic anion transporter (cMOAT) antisence cDNA enhanes drug sensitivity in human hepatic cancer cells. Cancer Res 1997; 57: 5475–5479. PubMed

Ben-Ezzer J, Blonder J, Shani M et al: Abnormal excretion of the isomers of urinary coproporphyrin by clinically unaffected family members. Isr J Med Sci 1973; 9: 1431–1436. PubMed

Rocchi E, Balli F, Gibertini P et al: Coproporphyrin excretion in healthy newborn babies. J Pediatr Gastroenterol Nutr 1984; 3: 402–407. PubMed

Kimura A, Yuge K, Kosai KI et al: Neonatal cholestasis in two siblings: a variant of Dubin-Johnson syndrome? J Paediatr Child Health 1995; 6: 557–560. PubMed

Nakata F, Oyanagi K, Fujiwara M et al: Dubin-Johnson syndrome in a neonate. Eur J Pediatr 1979; 4: 299–301. PubMed

Wolkoff AW, Cohen LE, Arias IM.: Inheritance of the Dubin-Johnson syndrome. N Engl J Med 1973; 288: 113–117. PubMed

Benz-de Bretagne I, Respaud R, Vourc'h P et al: Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans. J Biomed Biotechnol 2011; 2011: 498757. PubMed PMC

Laechelt S, Turrini E, Ruehmkorf A et al: Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. Pharmacogenomics 2011; 11: 25–34. PubMed

Kwan P, Wong V, Ng PW et al: Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistence in epilepsy. Pharmacogenomics 2011; 3: 319. PubMed